Evidence map›Paper›PMID 30830824›Full record

ArticleHealth affairs (Project Hope)2019

Understanding What Information Is Valued By Research Participants, And Why.

Consuelo H Wilkins, Brandy M Mapes, Rebecca N Jerome, Victoria Villalta-Gil, Jill M Pulley, Paul A Harris

Registry-linked trialAbstract read
In one paragraph

Article in Health affairs (Project Hope), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05277116 (The Electronic Medical Records and GEnomics), which is not on this map. Cited by 59 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05277116 naactive not recruitingnot on this mapstarted 2022, after this paper: background citation

The Electronic Medical Records and GEnomics (eMERGE) Network Genomic Risk Assessment

TypeinterventionalSponsorVanderbilt University Medical CenterRan2022 to 2030Enrolled26,877ConditionsGenetic DiseaseArmsGenome Informed Risk Assessment (GIRA) report
3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Return of Research Results to Participants in Longitudinal Cohort Studies in Health Research: Findings From 24 Cohorts of the Amsterdam Cohort Hub.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Ten simple rules for research with humans.PLoS computational biology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Developing a genetic return of results service core.Journal of clinical and translational science · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Consuelo H WilkinsConsuelo H. Wilkins ( consuelo.h.wilkins@vumc.org ) is the vice president for health equity, Vanderbilt University Medical Center, and an associate professor in the Department of Medicine, Vanderbilt University Medical Center, and the Department of Internal Medicine, Meharry Medical College, all in Nashville, Tennessee.
Brandy M MapesBrandy M. Mapes is a senior project manager in the Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center.
Rebecca N JeromeRebecca N. Jerome is a manager of translational research in the Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center.
Victoria Villalta-GilVictoria Villalta-Gil is a senior research specialist in the Meharry Vanderbilt Alliance.
Jill M PulleyJill M. Pulley is executive director of the Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center.
Paul A HarrisPaul A. Harris is director of the Office of Research Informatics in the Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center.

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
The RCMI Program in Health Disparities Research at Meharry Medical College - SupplementU54MD007586 · NIMHD · MEHARRY MEDICAL COLLEGE · PI Samuel Evans Adunyah, JAMES E HILDRETH · 2017 to 2026
$48.2M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Improving Clinical trial Education, Recruitment, and Enrollment at CTSA Hubs (I-CERCH) - HEAL SupplementU24TR001579 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARRIS, PAUL A., WILKINS, CONSUELO HOPKINS · 2016 to 2022
$34.1M
Technologies and Resources CoreU54MD007593 · NIMHD · MEHARRY MEDICAL COLLEGE · PI ADUNYAH, SAMUEL EVANS · 2012 to 2018
$24.7M
Training and Mentoring CoreU54MD010722 · NIMHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COX, NANCY J · 2016 to 2020
$11.9M
NCATS NIH HHS U24 TR001579NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1 TR002243NIMHD NIH HHS U54 MD007586NIMHD NIH HHS U54 MD007593NIMHD NIH HHS U54 MD010722
6 · The paper itself

Abstract

There is growing public demand that research participants receive all of their results, regardless of whether clinical action is indicated. Instead of the standard practice of returning only actionable results, we propose a reconceptualization called "return of value" to encompass the varied ways in which research participants value specific results and more general information they receive beyond actionable results. Our proposal is supported by a national survey of a diverse sample, which found that receiving research results would be valuable to most (78.5 percent) and would make them more likely to trust researchers (70.3 percent). Respondents highly valued results revealing genetic effects on medication response and predicting disease risk, as well as information about nearby clinical trials and updates on how their data were used. The information most valued varied by education, race/ethnicity, and age. Policies are needed to enable return of information in ways that recognize participants' differing informational needs and values.

Indexed as

Access to InformationAdolescentAdultAgedAge FactorsEducational StatusFemaleHumansMaleMiddle AgedPatient SelectionRacial GroupsResearch SubjectsSurveys and QuestionnairesTrustYoung Adult

Identifiers

PMID30830824
PMCPMC6706772

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.